Literature DB >> 17385663

Comparison and evaluation of two C-reactive protein assays based on particle-enhanced immunoturbidimetry.

Ali Riza Sişman1, Tuncay Küme, Gültekin Taş, Pinar Akan, Pinar Tuncel.   

Abstract

The use of C-reactive protein (CRP) assays is increasing for a wide range of clinical conditions, and consequently the analytical performance requirements for CRP assays are also changing. For this reason, manufacturers have been developing CRP assays based on different methodologies to provide both high sensitivity and a wide measuring range. However, it is questionable whether these methods can meet the desired requirements for CRP assays. CRP Latex on the Cobas Integra 400 and CRP Tina-quant Latex on the Modular Analytics-P were evaluated in terms of detection limit, linearity, intra- and interassay precision, and comparability with 268 patient samples. The intra- and interassay precision of the two methods was <4.1% in the three pools with CRP concentrations ranging from 6.9 to 215 mg/L, and >10% in the pool with concentrations of approximately 0.60 mg/L. The detection limits for CRP Latex and Tina-quant Latex were 0.20 and 0.22 mg/L, respectively. Both methods were linear up to 215 mg/L. There was a good agreement between the two assays, except for a scattering at concentrations near the detection limits. Deming regression analysis for CRP Latex (x-axis) and Tina-quant Latex (y-axis) yielded a slope of 1.067+/-0.018, an intercept of -0.148+/-0.358, and an S(y/x) of 5.10 (r=0.996, P<0.0001). The two assays gave comparable results. Low precision was determined for both assays, except for the low pool with a concentration of approximately 0.60 mg/L. We concluded that both of these assays should be improved to meet high-sensitivity criteria. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17385663      PMCID: PMC6648996          DOI: 10.1002/jcla.20141

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  21 in total

1.  General deming regression for estimating systematic bias and its confidence interval in method-comparison studies.

Authors:  R F Martin
Journal:  Clin Chem       Date:  2000-01       Impact factor: 8.327

2.  Lack of seasonal variation in C-reactive protein.

Authors:  Margit Fröhlich; Malte Sund; Barbara Thorand; Winston L Hutchinson; Mark B Pepys; Wolfgang Koenig
Journal:  Clin Chem       Date:  2002-03       Impact factor: 8.327

Review 3.  Coming of age of C-reactive protein: using inflammation markers in cardiology.

Authors:  Edward T H Yeh; James T Willerson
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

Review 4.  The C-reactive protein.

Authors:  B Clyne; J S Olshaker
Journal:  J Emerg Med       Date:  1999 Nov-Dec       Impact factor: 1.484

5.  Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects.

Authors:  H K Meier-Ewert; P M Ridker; N Rifai; N Price; D F Dinges; J M Mullington
Journal:  Clin Chem       Date:  2001-03       Impact factor: 8.327

6.  Comparing methods of measurement: why plotting difference against standard method is misleading.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321

7.  Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

Authors:  P M Ridker; N Rifai; M A Pfeffer; F M Sacks; L A Moye; S Goldman; G C Flaker; E Braunwald
Journal:  Circulation       Date:  1998-09-01       Impact factor: 29.690

8.  C-reactive protein fifty years on.

Authors:  M B Pepys
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

9.  C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women.

Authors:  Paul M Ridker; Julie E Buring; Nancy R Cook; Nader Rifai
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

10.  Standardization of immunoassays for measurement of high-sensitivity C-reactive protein. Phase I: evaluation of secondary reference materials.

Authors:  Mary M Kimberly; Hubert W Vesper; Samuel P Caudill; Gerald R Cooper; Nader Rifai; Francesco Dati; Gary L Myers
Journal:  Clin Chem       Date:  2003-04       Impact factor: 8.327

View more
  9 in total

Review 1.  Socioeconomic position and inflammatory and immune biomarkers of cardiovascular disease: applications to the Panel Study of Income Dynamics.

Authors:  Allison E Aiello; George A Kaplan
Journal:  Biodemography Soc Biol       Date:  2009

2.  Disposable paper-based electrochemical sensor using thiol-terminated poly(2-methacryloyloxyethyl phosphorylcholine) for the label-free detection of C-reactive protein.

Authors:  Chanika Pinyorospathum; Sudkate Chaiyo; Pornpen Sae-Ung; Voravee P Hoven; Panittha Damsongsang; Weena Siangproh; Orawon Chailapakul
Journal:  Mikrochim Acta       Date:  2019-06-26       Impact factor: 5.833

Review 3.  Role of C-Reactive Protein in Diabetic Inflammation.

Authors:  Julijana Stanimirovic; Jelena Radovanovic; Katarina Banjac; Milan Obradovic; Magbubah Essack; Sonja Zafirovic; Zoran Gluvic; Takashi Gojobori; Esma R Isenovic
Journal:  Mediators Inflamm       Date:  2022-05-17       Impact factor: 4.529

Review 4.  Diagnoses Based on C-Reactive Protein Point-of-Care Tests.

Authors:  Miroslav Pohanka
Journal:  Biosensors (Basel)       Date:  2022-05-17

5.  Comparison of novel and familiar commercial kits for detection of C-reactive protein levels.

Authors:  Ihsan Hakkı Ciftci; Mehmet Koroglu; Engin Karakece
Journal:  World J Microbiol Biotechnol       Date:  2014-05-10       Impact factor: 3.312

Review 6.  Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

Authors:  Joao Tomé-Carneiro; Mar Larrosa; Antonio González-Sarrías; Francisco A Tomás-Barberán; María Teresa García-Conesa; Juan Carlos Espín
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

7.  Sensitive and rapid quantification of C-reactive protein using quantum dot-labeled microplate immunoassay.

Authors:  Yang Luo; Bo Zhang; Ming Chen; Tianlun Jiang; Daiyang Zhou; Junfu Huang; Weiling Fu
Journal:  J Transl Med       Date:  2012-02-06       Impact factor: 5.531

8.  A comparison study between wide-range and high-sensitivity C-reactive protein assays (Roche Cobas c702) for low C-reactive protein concentration in patients with cardiovascular risk.

Authors:  Runqing Li; Yajun Xue; Tengjiao Wang; Lijun Gong; Peng Peng; Pan Xiong; Mingzhu Dai; Tongju Shao; Yuhan Hu; Xinchen Ye
Journal:  J Clin Lab Anal       Date:  2019-06-20       Impact factor: 2.352

9.  Elevation of fibrin degradation product (FDP) values prevents the negative conversion of serum CRP values after total knee arthroplasty.

Authors:  Takuya Fujimoto; Takao Kaneko; Takahide Sunakawa; Hiroyasu Ikegami; Yoshiro Musha
Journal:  J Orthop       Date:  2018-08-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.